Shandong Boyuan Pharmaceutical & Chemical Co., Ltd. Stock Price

Shandong Boyuan Pharmaceutical & Chemical Co., Ltd. engages in the research and development, production, and sale of fine chemicals in China. It operates in four segments: Iodine Derivatives, Industrial Catalysts (precious metals), Organosilicon Series, and Chemiluminescent Materials. The company offers iodine derivatives, such as potassium iodide, sodium iodide, potassium iodate, hydriodic acid, copper iodide, and iodotrimethylsilane; and fine chemicals, including hexamethyldisilazane, hexamethyldisilane, hexamethyldisiloxane, tris(dioxa-3,6-heptyl)amine, and tris[2-(2-methoxyethoxy)ethyl]amine. It also provides chemiluminescent products comprising 3,5-dichlorosalicylic acid; 3,5,6-trichlorosalicylic acid; bis(2,4,5-trichloro-6-carbopentoxyphenyl) oxalate; and bis(2,4,5-trichloro-6-i-pentoxycarbonylphenyl) oxalate. In addition, the company offers precious metal catalysts, such as rhodium(ii) octanoate dimer, rhodium(iii) iodide, wilkinson’s catalyst, palladium acetate, rhodium(iii) chloride hydrate, palladium chloride, chloroplatinic acid hexahydrate, potassium platinochloride, potassium hexachloroplatinate, ruthenium(iii) chloride hydrate, rhodium (triphenylphosphine)carbonylacetylacetonate, tetrakis(triphenylphosphine)palladium, palladium on carbon, and ruthenium on carbon. Its products are used in the field of pharmaceutical, food, chemical industry, new materials, optoelectronic semiconductor, etc. The company also exports its products. Shandong Boyuan Pharmaceutical & Chemical Co., Ltd. was founded in 2008 and is headquartered in Shouguang, China.